Skip to content
Future Fields logo

Future Fields

Future Fields is a YC Summer 2020 (S20) company. Based in Edmonton, AB, Canada. Team of 34.

  • Biotech
  • Manufacturing
  • Climate

About Future Fields

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Future Fields builds a multicellular biomanufacturing platform that produces recombinant proteins that conventional systems cannot make. Biotech, life sciences, and pharma companies use it to source proteins that would otherwise stall or fail in standard expression systems. The platform replaces traditional single-cell manufacturing approaches with a more capable biological production process.

From the Y Combinator listing

How Future Fields describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

We make unmakeable proteins with radical advanced biomanufacturing.

Future Fields has developed the world's first multicellular advanced biomanufacturing platform for the production of the most challenging recombinant proteins. We help companies in biotech, life sciences, and pharma by manufacturing their proteins.

Facts

Industry
Healthcare / Healthcare -> Industrial Bio
Location
Edmonton, AB, Canada
Team size
34
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works